The transcription factor nuclear factor kappa B (NFjB) controls the expression of over 400 genes, some of which are associated with reproductive events. During implantation, immune cells accumulate in the maternal-fetal interface; they secrete inflammatory mediators under the control of NFKB, the level of which also rises. NFKB is then downregulated to maintain gestation, but its level rises again before birth to manage prostaglandin, cytokine, and chemokine synthesis, and to stimulate uterine contraction. This review summarises the current state of knowledge about NFjB and its role in the molecular regulation of processes related to pregnancy development.
Introduction
The success of pregnancy requires the adaptation of the maternal cardiovascular and immune systems to the needs of the developing fetus. This is made possible by maternal-fetal crosstalk, which is crucial for implantation, placentation, and the remodelling of uterine vasculature, and by the development of maternal immune tolerance, which is essential for conceptus survival. 1 Nuclear factor kappa B (NFjB) is a transcription factor involved in the regulation of genes related to inflammation and immune response. NFjB is believed to play important roles in opening the implantation window, the first stage of implantation, and the initiation of labour in mammals. [2] [3] [4] All of these processes are characterised by a specific immunological response at the maternal-fetal interface that allows trophoblast invasion and angiogenesis, protects maternal tissue from trophoblast over-invasion in early pregnancy, and stimulates uterine contraction during labour. 5 Moreover, NFjB expression needs to be closely managed to maintain the cytokine profile required for the maternal acceptance of fetal tissue. 6 This review examines the current state of knowledge about the role of NFjB in implantation and parturition, and in the maintenance of pregnancy. As the molecular mechanism of NFjB in humans remains poorly understood, especially during early pregnancy, this review also includes studies based on animal models and the pathology of gestation.
NFjB and the process of implantation
Changes in maternal inflammatory response are required to initiate and maintain gestation. Generally, pregnancy is linked with maternal immunosuppression, and the maternal T helper lymphocytes type 1 (Th1) response shifting towards T helper lymphocytes type 2 (Th2). An intense maternal inflammatory reaction is observed upon implantation, followed by an increase in the levels of T helper lymphocytes (Th1), proinflammatory cytokines, such as interleukin 6 and 8 (IL-6 and IL-8), and tumour necrosis factor alpha (TNFa) and interferon gamma (IFNc), which are secreted by the endometrial cells, and various maternal immunological cells: natural killer (NK) cells, macrophages, and dendritic cells (Figure 1) . 7, 8 Both IL-6 and IL-8 are stimulators of trophoblastic cell migration and invasion, as confirmed in the first-trimester cytotrophoblast and HTR-8/SVneo cell line. 9, 10 A reduction of IL-6 and IL-8 secretion by decidual uterine NK cells and macrophages is observed in women suffering from spontaneous miscarriage. 11 In contrast, trophoblast migration is inhibited by TNFa and INFc, thus protecting maternal tissue against trophoblast over-invasion by a mechanism based on trophoblastic cell apoptosis. 8, 12, 13 All of these inflammatory mediators (IL-6, IL-8, TNFa, and INFc) are controlled by NFjB. NFjB itself has been found to be an important mediator for activating IL-6 gene expression in two human cell lines (U-937 and HeLa) following induction by various agents.
14 A possible binding site for NFjB is known to exist between nucleotides À75 and À63 of the 5 0 flanking region of the IL-6 gene. Variations of the DNA sequence in this region prevent the induction of the IL-6 promoter in U-937 cells, and also markedly reduce IL-6 gene expression in HeLa cells. 14 NFjB also regulates the gene expression of IL-8. IL-8 production in stimulated Jurkat T lymphocytes is completely inhibited by the use of an antisense oligonucleotide to NFjB mRNA, and more specifically, the RelA subunit mRNA. 15 Two other studies, one based on T-cell populations (T helper CD4+ from spleen and lymph nodes) and the second on a macrophage cell line, found NFjB to be implicated in the regulation of INFc and TNFa gene expression, respectively. 16, 17 Moreover, crosstalk between TNFa and INFc is important for the activation of NFjB, which in turn is required for the production of CXC10, a chemokine engaged in the migration of trophoblastic cells at an early stage of the pregnancy. 18, 19 Human endometrial epithelial cells obtained throughout the menstrual cycle, and porcine and murine animal models have demonstrated NFjB activation in the mammalian endometrium to be associated with the activation of interleukin 1beta (IL-1b) or with the control of leukaemia inhibitory factor (LIF) expression, which determine the timing of implantation. 4, [20] [21] [22] Evidence from mammalian animal models indicates that NFjB (p65 and p50 subunits) levels increase in pig endometrium between days 5 and 12 of the oestrus cycle before pregnancy, and that the NFjB level also shows a tendency towards increasing in the first stage of pregnancy. [22] [23] [24] Elsewhere, it has been noted that the suppression of NFjB activation in mouse uterus cells and the subsequent inhibition of nuclear translocation delays the process of implantation. 4 A complete loss of NFjB (subunit RelA) synthesis in RelA knock-out mice results in death. 25 A study conducted on human endometrium samples taken in the last menstrual period and from the decidua of the first trimester also confirm that NFjB levels are typically elevated during the premenstrual phase, and that this is essential for the first step of gestation. 2 NFjB activation differs between the two phases, however. It is believed that NFjB activation follows the classical pathway in the premenstrual endometrium, demonstrated by the elevated expression of the inhibitor of nuclear factor kappa B kinase subunit beta (IKKb) and the inhibitor of nuclear factor kappa B kinase subunit gamma (IKKc) genes, whereas it follows an alternative IKKa-NIK (inhibitor of nuclear factor kappa B kinase subunit alpha -nuclear factor kappa B-inducing kinase) dependent pathway in the decidua of the first trimester. 2 Regardless of the NFjB activation pathway, it is thought that NFjB may be involved in the regulation of both animal and human uterine function, and the correct course of early pregnancy. 22 In a non-complicated gestation, the muscular layer of maternal spiral arteries is destroyed by the invasive trophoblast, and the vessels of the uterus are converted into low-resistance and high-capacitance channels to supply oxygen and nutrients to the developing conceptus. The process of trophoblast invasion depends on the secretion of metaloproteinases (MMPs), especially MMP1, MMP2, MMP3 and MMP9, the expression of which is regulated by NFjB (Figure 1) . The NFjB binding site is located between bases À3030 and À3000 of the MMP1 promoter region, 26 with NFjB-like elements from À1189 to À1180 and from À528 to À519 in MMP2. 27 In MMP3, the NFjB binding site includes the region between -1608 and -1612, however, 28 and is found between -600 and -591 in MMP9. 29, 30 Together with the invading trophoblast cells, MMPs are also expressed by endometrial stromal cells, and by NK cells and macrophages of the decidual area ( Figure 1 ). 31, 32 Tests on animal models indicate that an increased level of MMP2 and MMP9 is observed in the endometrial stroma of the uterus during early pregnancy in mice, and this level significantly decreases in areas that undergo decidualisation. 33 The binding of NFjB to the MMP2 gene promoter region plays an important role in the direct regulation of MMP2, as noted in telomerase-immortalised human Swan 71 first-trimester trophoblast cells stimulated by granulocyte colony-stimulating factor (G-CSF). 34 Studies on human endometrial stromal cells obtained by hysterectomy in patients aged 38-45 years old, and in female mice, indicate that the upregulation of MMP9 gene expression is also directly dependent on NFjB activation, which takes place after a reduction of progesterone caused by the progesterone receptor antagonist RU486. 35 Progesterone withdrawal is observed in the mammalian endometrium at the beginning of pregnancy. 22, 36, 37 It is thought that during early gestation, an elevated progesterone level induces the downregulation of its own receptor in the endometrium. 22, 36 A previous in vitro study found that the mutual repression of progesterone receptor (PGR) and NFjB occurs in tissue targeted by progesterone, 38 and is regulated by the three pathways described by Davies et al. 39 This crosstalk could also be an important mechanism of controlling cytokine release during pregnancy; it also situates NFjB as an important factor in the opening of the implantation window when the conceptus attaches to the uterine surface and develops a communication network between mother and fetus. 22 The developing conceptus secretes estrogen acting via its receptor. A study of HTR-8/SVneo (human first-trimester trophoblast) cells and Ishikawa endometrial cancer cells found that the estrogen receptor (ER) and NFjB inhibit one another. 40 Mutual repression was also observed between NFjB and ER in vivo in ovariectomised C57BL/6 mice suffering from atherosclerosis, as well as in various in vitro models based on cancer cell lines, e.g. HepG2. 41, 42 The mechanism of mutual repression between NFjB and ER is based on the reciprocal inhibition of transcription, prevention of NFjB activation, or the binding of NFjB to DNA. 43 Increasing levels of progesterone and estrogen accompanying the development of pregnancy could lead to reduced NFjB activation (Figure 2) . Some in vitro studies indicate that both hormones mediate the increased expression of the NFjB inhibitor, IKBa, thus downregulating NFjB activation, which is required for a successful pregnancy. 6, 44, 45 NFjB and the maintenance of pregnancy
In contrast to the implantation stage, the maintenance stage is typified by a lower level of NFjB. The further development and maintenance of pregnancy depends on alterations in the maternal T-cell immunoresponse; these changes are necessary to avoid rejecting the fetus, whose tissues are recognised by the maternal immune system as an allograft. 46 To maintain gestation, the maternal immune response is shifted from Th1 and Th17 towards Th2 and the regulatory T cells (Treg) (Figure 2 ). Both the Th2 and Treg lymphocytes are involved in humoral immunity and the induction of tolerance. Tregs express various cytokine receptors, and their ligands are expressed at the maternalfetal interface; this might encourage chemokine-mediated migration of Tregs to the decidua. 5 Interestingly, Treg cell development in the thymus is strongly related to the NFjB signalling pathway. Long et al. 47 studied two populations of transgenic mice, one with enhanced NFjB activity and the other with reduced activity; they found that NFjB is positively implicated in the regulation of Foxp3 gene expression, with Foxp3 being one of the main regulators of Treg cell development. 47 The forced expression of Foxp3 causes it to interact with NFjB, however, and blocks its ability to induce NFjB -dependent gene expression, resulting in the inhibition of IL-2, IL-4, and IFNc production in T cells. 48 Decreased levels of IL-2 and IFNc are essential for immunosuppression and the maintenance of maternalfetal tolerance during pregnancy. 49, 50 The importance of NFjB inhibition in the T cells of pregnant women is highlighted by McCracken et al. in a study of T cells isolated from ten healthy pregnant and ten non-pregnant women. 6 Western blotting found high levels of NFjB (p65) in both the nuclear and the whole-protein fractions of T cells from non-pregnant women, whereas electrophoretic mobility shift assay (EMSA) found that pregnant women had less active NFjB than those who were not expecting. 6 The authors suggest that the gestationspecific suppression of NFjB plays a central role in the reduction of cytokine production by Th1, and in the maintenance of the cytokine profile necessary for pregnancy. 6 These findings support previous observations that mice with a defective NFjB activation pathway can only mount a Th2 immune response to infections. 51 Hence, it is possible that NFjB inhibition may be responsible for the gestational shift of maternal immunological response from Th1 towards Th2 observed in numerous studies (Figure 2) .
The level of NFjB in maternal T cells may be regulated not only by steroid hormones or cytokines, as mentioned earlier, but also by the placenta. During pregnancy, microparticles or exosomes derived from the placenta appear in the maternal circulation. McCracken et al. note that FasL+ exosomes in maternal plasma regulate NFjB levels in circulating maternal T cells through Fas activation. 46 The activation of Fas, a type-I transmembrane protein of T cells, by exsosomal FasL results in the creation of a suitable cytokine profile for pregnancy by the suppression of NFjB (Figure 2) . Changes in the level of FasL in placental-derived exosomes during pregnancies complicated by intrauterine growth restriction (IUGR) may therefore alter Fas/FasL signalling, thus preventing the decrease in NFjB level and moderation of T-cell function. 46 Activated T cells express a high level of proinflammatory cytokine: elevated levels of IL-1, IL-2, IL-6, IL-8, TNFa, and IFNc in maternal blood were observed in pregnancies complicated by IUGR or pre-eclampsia. [52] [53] [54] [55] These cytokines promote the development of inflammatory reactions of the maternal immune system, inter alia, by the translocation of NFjB into the nucleus. In monocytes isolated from peripheral blood mononuclear cells (PBMCs) of healthy and non-pregnant women, Rahardjo et al. found significantly higher levels of nuclear-fraction NFjB in those incubated with the blood plasma of women with pre-eclampsia than with the blood plasma taken from normotensive pregnancies. 55 Moreover, it is thought that inflammatory cytokines, especially TNFa, induce the elevated activation of NFjB in placental cells. A study on ED 27 trophoblast-like cells incubated with 2 ng/ml of TNFa displayed significantly greater activation of NFjB, compared with controls. 56 The effect of intensified activation of NFjB is observed in some pathologies reserved for pregnancy: e.g. preeclampsia and IUGR. 56, 57 Aban et al. report that an increased level of NFjB in pre-eclamptic and IUGR placentas is associated both with the downregulation of antiapoptotic Bcl-2 and with the elevation of proapoptotic caspase-3, suggesting that placental trophoblastic apoptosis depends on the NFjB pathway. 57 Ryan et al. note that NFjB plays a role in the p53-mediated programmed cell death pathway. 58 Both Bcl-2 and p53 are under the control of NFjB, and they act in opposition, which is important for the physiology of gestation. [59] [60] [61] A study on the placentas of rhesus monkeys found Bcl-2 protein to be responsible for cell survival, whereas p53 plays an essential role in the regulation of trophoblast proliferation and apoptosis. 60 These observations were confirmed on human placenta samples from various stages of pregnancy by the teams of Soni and Marzusch.
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NFjB and labour
The suppression of NFjB activity may not only be important for maintaining pregnancy but also for preparing the mother and the fetus for the onset of labour. 3 While the uterus is maintained in a quiescent state during pregnancy, it becomes sensitised to uterotonins during the onset of labour, when it is transformed into a contractile organ. Remodelling also takes place in fetal membranes and the cervix, which is prepared for progressive dilatation and delivery. 64, 65 The fetal membranes consist of an amnion and chorion, connected by an extracellular matrix (ECM). One of the main components of the ECM is collagen, various types of which (I, III, IV, V, VI) are distributed throughout the layers of the fetal membranes and are degraded by various metaloproteinases. 66 MMPs not only disrupt the fetal membranes, but also digest the collagens localised in the ECM of the cervix, thus enabling cervical ripening and dilation. 67 A range of ECM-degrading MMPs, particularly MMP1, MMP2, MMP3, and MMP9, are produced by the fetal membranes, cervix, placenta, and inflammatory cells within the uterine tissues.
3,68-70 MMP gene regulation is controlled by NFjB, as mentioned in a previous section (Figure 3) .
The onset of labour is associated with increased levels of proinflammatory cytokines such as IL-1b, IL-6, and TNFa. They are found in the amniotic fluid during preterm and term labour, whereas IL-1b and IL-6 are also found in the amnion, myometrium, choriodecidua, and cervicovaginal secretions ( Figure 3) . 3 IL-1b, IL-6, or TNFa expression is related to the activation, nuclear translocation, and binding of NFjB to recognition elements within the cytokine promoter regions. Interestingly, the same cytokines (IL-1b, IL-6, and TNFa) are responsible for NFjB activation and its translocation into the nucleus. The blockage of NFjB nuclear translocation is linked with the inhibition of Figure 3 . The regulation of factors associated with parturition by NFjB. An elevated level of active NFjB influences the regulation of: COX-2, IL-1B, IL-6, IL-8, MMPs, OXTR, and prostaglandins (PGs) in the amniotic fluid, fetal membranes, uterus, and placenta. All these factors participate in the processes required for successful delivery (e.g. inflammation, cervical ripening, fetal membrane rupture, and uterus contraction). synthesis of cyclooxygenase type 2 (COX-2), a potent mediator of labour, in amnion cells. 71 Allport et al. found constitutive activity of NFjB in amnion cells at the time of labour and noticed that NFjB acts to increase the expression of COX-2.
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In addition, in the third trimester of gestation the IL-8 level is elevated under the influence of NFjB, and this is accompanied by an increased synthesis of prostaglandins, especially prostaglandin E 2 (PGE 2 ). IL-8 is present both in the chorion-decidua and within the amnion and amniotic fluid, 64, 65, 72, 73 whereas the major source of PGE 2 is represented by the amnion cells, in which prostaglandin gene expression is regulated by NFjB. 74 Elevated levels of IL-8, COX-2, and prostaglandins are observed during labour at term and preterm ( Figure 3) . 64, 65, [72] [73] [74] [75] [76] Elevated activation of NFjB in the amnion and human myometrium was also confirmed by Chapman et al. in a study examining the expression of NFjB family members (p50, RelA, c-Rel, p100, and p105) in human myometrial tissues obtained from non-pregnant women (NP), healthy women undergoing elective caesarean section at term (P), and from women with spontaneous labour undergoing caesarean section at term (SL). 77 Their findings indicate a specific pattern of expression of each NFjB subunit in the human myometrium during pregnancy and labour. Moreover, the myometrium of the non-pregnant group displayed elevated levels of p50 homodimers, which were replaced by RelA-p50 heterodimers in samples from pregnant and labouring women. They conclude that an elevated level of the stimulatory RelA-p50 heterodimer is critical for the activation of the myometrium, and its preparation for contraction and labour: the p50 homodimer is generally associated with transcriptional repression, and the RelAp50 complex is an activator of gene expression. 77 The translocation of NFjB into the nucleus may modify the expression of the genes responsible for myometrial smooth muscle quiescence. An elevated level of Gas expression in the myometrium during gestation favours uterine relaxation and enhances the formation of cyclic adenosine monophosphate (cAMP). 78 cAMP elevation leads to the activation of protein kinase A (PKA), which facilitates the phosphorylation of nuclear proteins, including the cAMP response element binding protein (CREB). Together with CREB binding protein (CBP), CREB increases the expression of Gas in the myometrium, leading to myometrial quiescence. 78, 79 The induction of NFjB by proinflammatory mediators during gestation enables nuclear competition between NFjB and CREB for CBP. CBP can be removed from the Gas-regulatory region; it represses quiescence-associated gene expression and regulates the key mediators of labour. 79 Some studies suggest that NFjB may also cooperate in the nucleus with other transcription factors such as activator protein 1 and CCAAT/enhancer-binding protein (CEBP), which together may regulate the transcriptional activity of various labour-associated genes. [80] [81] [82] [83] The dramatic increase in oxytocin receptor expression in the uterine tissues at the end of pregnancy, and the fact that pharmacological inhibition of the oxytocin receptor delays delivery, suggests that oxytocin and its receptor are essential for normal labour. 84 The promoter region of the oxytocin receptor gene (OXTR) includes three possible binding sites for NFjB transcription factor and a few for CEBP. 85 Khanjani et al. propose that oxytocin receptor gene regulation depends on the synergistic cooperation of NFjB and CEBP, and that the cooperation and binding of both transcription factors to the OXTR gene is increased by IL-1b, the expression of which is also regulated by NFjB. 86 To summarise, NFjB has been implicated in numerous processes related to human labour. Literature data indicate that an elevated NFjB level at term is linked with the following processes: (1) activation of metalloproteinases, implicated in the degradation of fetal membranes as well as in the preparation of the reproductive system for an influx of inflammatory cells; (2) regulation of the inflammatory response, which allows the stimulation of COX-2 and prostaglandins; (3) control of COX-2 gene expression; and (4) regulation of gene expression of contraction-associated protein and the oxytocin receptor. In addition, an elevated NFjB level is associated with various other effects not described in the present study, such as progesterone withdrawal, which is crucial for labour. Therefore, the use of drugs that directly counter the action of NFjB may represent a more effective approach than the standard current treatment for the management of human labour.
Conclusion
A considerable body of experimental evidence suggests a strong association between NFjB and the development of pregnancy. NFjB is perceived as an important regulator of implantation, and one that plays an important role in the induction of parturition induction. 2, 3 Moreover, the maintenance of pregnancy depends on the inhibition of NFjB. 6 An incorrect level of NFjB for the appropriate stage of pregnancy may predispose women to obstetric complications. Disturbances in NFjB inhibition or its level are associated with the development of the following pregnancy disorders: IUGR, pre-eclampsia, and premature labour. 3, 56, 57 Knowledge about the management of NFjB level in physiological and pathological pregnancy could provide the basis for the development of new strategies of treatment. The design of targeted therapy directly against NFjB seems promising and could be more effective than the current methods of medication.
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